NCT03629340View on ClinicalTrials.gov

Metformin for Pulmonary Hypertension HFpEF

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Pulmonary HypertensionHeart Failure
Interventions
DRUG

Metformin

500 mg PO BID x 1 week then increase to 1000 mg PO BID x 11 weeks

DRUG

Placebo oral capsule

Placebo capsule that is of identical size, shape, and color to experimental drug capsule PO (by mouth) BID (two times each day) for 12 weeks

Trial Locations (2)

15213

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

94143

RECRUITING

UCSF Medical Center, San Francisco

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, San Francisco

OTHER